FindTrial
Sign In

Comparitive Evaluation of Kshar gutika along with Tankan bhsma kawal alone in the management of Tundekeri ( Inflammation or Redness of Tonsillis which is present in throat ) A Randomized Control Trial

Comparitive Evaluation of Kshar gutika along with Tankan bhsma kawal alone in the management of Tundekeri ( Acute catarrhal Tonsillitis ) A Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104761
Enrollment
126
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B088- Other specified viral infections characterized by skin and mucous membrane lesions

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurved College Hospital and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient of either sex aged between 10 to 35 yr

Exclusion criteria

Exclusion criteria: Patient suffering from Membranous Tonsillitis and Parenchymatous Tonsillitis associated with Peritonsillar abscess, Tonsillar cyst Patient who are contraindicated for kawal

Design outcomes

Primary

MeasureTime frame
Study outcome will be a major benefit for tonsillitis patient.Kshar gutika will be a best and easy to take drug for an irritative symptoms of Tundekeri and according to dosha vighatna it will be a best medicine for Tonsillitis.Timepoint: 2 weeks—

Secondary

MeasureTime frame
NillTimepoint: NILL—

Countries

India

Contacts

Public ContactDr Pooja Panwar

mahatma gandhi ayurved college, hospital and research centre

drpoojapanwar1@gmail.com8630942340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026